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Abstract
Background: While declines in muscle mass and function occur in all individuals with advancing age, the extent
and rate of decline vary in the general population. We aimed to determine the prevalence of low lean tissue mass
combined with poor physical function as an indicator of sarcopenia among older men and women residing in south-
eastern Australia.
Methods: The study involved men and women aged 60+ years from the Geelong Osteoporosis Study (GOS).
Skeletal muscle mass was measured as total lean tissue mass by dual energy x-ray absorptiometry (DXA) and
expressed as a percentage of body weight to generate the skeletal mass index (SMI); low lean mass was defined as
SMI T-score <-1. Low muscle function was based on performance using “timed up-and-go” scores >10s. Physical
activity scores were determined using a validated questionnaire for the elderly and falls were self-reported for the
previous year. Associations between sarcopenia, physical activity and falls were determined using multivariable
regression techniques.
Results: Among 624 men, 233 had low SMI, 169 had low muscle performance and 81 had both, thus meeting
criteria for sarcopenia. Among 436 women, 143 had low SMI, 179 had low muscle performance and 70 had both. A
general age-related increase in the observed prevalence of sarcopenia appeared to be driven by an age-related
increase in low performance. Sarcopenia was associated with lower physical activity scores. No association was
detected between sarcopenia and falls for men but an association was observed for women (age-adjusted OR 1.87,
95% CI 1.11, 3.14).
Conclusion: In our population, the prevalence of sarcopenia was 10.6% (95% CI 7.7, 13.4) for men and 14.5%
(95% CI 10.8, 18.3) for women. Men and women with sarcopenia were habitually less active and, for women,
sarcopenia was associated with increased likelihood of falls.
Keywords: Lean mass; Skeletal muscle mass; Muscle function;
Physical performance; Sarcopenia; Ageing; Frailty; Falls
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Introduction
The term “sarcopenia” (taken from the Greek to mean “poverty of
flesh”) was coined by Rosenberg to describe progressive changes in
body composition that involve generalised loss of skeletal muscle mass
[1]. While such a decline occurs in all individuals with advancing age,
the extent varies on a continuum that gradually impacts on mobility,
independence and frailty [2]. While there are several definitions of
sarcopenia, we have referred to recommendations developed by the
European working group on sarcopenia in older people (EWGSOP)
that sarcopenia be defined in terms of loss of skeletal muscle mass and
function [2]. In this study, lean tissue mass measures derived from
dual-energy x-ray absorptiometry (DXA) and performance in the
“timed up-and-go” (TUG) test served as indicators of skeletal muscle
mass and function.
We aimed to determine the age-related prevalence of sarcopenia and
its components in older men and women living in south-eastern
Australia and to investigate this condition in association with habitual
physical activity and falls.
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Materials and Methods
Subjects
The study is set in the Barwon Statistical Division and forms part of
the large prospective cohort study known as the Geelong Osteoporosis
Study (GOS). Age-stratified samples of 1,540 men and 1,494 women
were recruited at random from Commonwealth electoral rolls in the
years 2001-2006 and 1994-1997, with 67% and 77% participation,
respectively. Inclusion criteria were that the participants were
registered on the electoral rolls for the Barwon Statistical Division and
had resided in the region for at least six months. Participants were
excluded if they were unable to provide written informed consent to
participate in the study. Age at recruitment ranged from 20-97 years
for men and 20-94 years for women. Participants are recalled every 2-5
years for re-assessment. Details of recruitment, follow-up and
retention have been described elsewhere [3]. For this cross-sectional
analysis, we included individuals aged 60 years and older, and utilised
data for men at baseline and for women at 6-year follow-up. Among
651 men and 463 women who participated at these assessment phases
and were of appropriate age, 624 men and 436 women provided data
on both skeletal muscle mass and function, fulfilling inclusion criteria
for this analysis. As a reference sample, we used lean tissue and whole
body mass measures of men and women aged 20-39 years, for
quantifying deficits in lean tissue muscle mass of the older participants.
The study was approved by the Human Research Ethics Committee at
Barwon Health. All participants gave informed, written consent.
Measures
Height and weight were measured to the nearest 0.1 cm and 0.1 kg,
respectively, and body mass index (BMI) calculated as weight/height2
(kg/m2). DXA scans were performed using Lunar densitometers (DPX-
L or Prodigy-Pro, Madison, WI, USA) to provide measures of lean
tissue mass. Lean tissue assessed by this technology comprises non-fat
and non-bone tissue, and this measure correlates well with skeletal
muscle mass quantified by magnetic resonance imaging [4]. Our group
has previously reported age-and-sex-specific normative data for lean
tissue mass obtained from DXA [5]. We have used the skeletal mass
index (SMI) which was calculated by expressing the lean tissue mass as
a percentage of body mass [6]. SMI values for men and women aged
20-39 years were normally distributed and served as the young adult
reference group in order to calculate T-scores for SMI values among
older study participants. The younger individuals were also assessed as
part of the GOS and comprised 377 men with mean SMI (SD) value of
74.6% (7.7) and 437 women with mean SMI (SD) value of 60.4%
(8.6%). Low SMI for defining low lean tissue mass was T-score <-1.0,
using sex-specific thresholds (cut-points) of 66.9% for men and 51.8%
for women. Physical performance was assessed using the TUG test
over a distance of 3 m, and a time >10s was used to indicate low
performance [7]. By definition, the TUG measures the time taken to
stand from a seated position in a chair, walk a measured distance of
3m, turn around, walk back and sit down again. While performing the
TUG, participants wore normal shoes and used habitual walking aids.
In this analysis we have designated individuals with sarcopenia as
those with SMI T-score <-1 and TUG >10s.
Habitual physical activity levels were assessed using a questionnaire
for the elderly [8] wherein a physical activity score was generated by
combining scores for household, sport and leisure activities. For this
group of older men and women, physical activity scores ranged from
0.2-66.9. Falls during the past 12 months were documented by self-
report and those who reported one or more falls were classified as
fallers.
Statistical analysis
To obtain the prevalence of sarcopenia, the age-stratified samples
were standardised to the national age-profile (Australia, 2001).
Characteristics of these older men and women were compared
according to the presence or absence of sarcopenia using t-tests or
Mann-Whitney tests for continuous data and the test for proportions
for categorical data. The natural log of the TUG scores and the square
root values of the physical activity scores were calculated to normalise
the data before analysis.
The Pearson product moment correlation coefficient was used to
describe the degree of linear relationship between transformed TUG
scores, lean tissue mass and age. Associations between sarcopenia and
transformed physical activity scores and falls were determined using
multivariable regression techniques, adjusting for age. The models were
checked for interaction terms. All statistical analyses were performed
using Minitab (version 16; Minitab, State College, PA).
Results
Subject characteristics are shown in Table 1. Compared to
individuals without sarcopenia, those with sarcopenia were older,
heavier, had a higher mean BMI and poorer physical activity scores.
Lean tissue mass was negatively correlated with age for both men
(r=-0.38, p<0.001) and women (r=-0.33, p<0.001). Men with
sarcopenia had lower lean tissue mass than those without sarcopenia,
but this difference was not observed for women. The proportion of
men with low SMI varied little across the age range for men; a similar
pattern was observed for women in their 60s and 70s, but was reduced
for women aged 80 years and older (Figure 1).
The log-transformed TUG scores were positively correlated with age
for both men (r=+0.44, p<0.001) and women (r=+0.53, p<0.001); there
was a marked age-related increase observed in the proportion of men
and women with low physical performance (high TUG scores).
For men, 233 (37.3%) had low SMI, 169 (27.1%) had low physical
performance and 81 (13.0%) had both, meeting criteria for sarcopenia.
An overall increase in the prevalence of sarcopenia was observed for
men, ranging from 3.8% (95% CI 1.0, 9.5) for age 60-64 years to 31.1%
(95% CI 19.9, 44.3) for 85+ years (Figure 1).
The age-standardised prevalence of sarcopenia for men aged 60
years and older was 10.6% (95% CI 19.9, 44.3). Sarcopenia was
associated with lower physical activity scores (Age-adjusted mean 8.8
(7.2-10.5) vs 14.7 (13.9-15.5), p<0.001) but no association was
observed with falls (Age-adjusted OR 0.99 (95% CI 0.60, 1.63), p=0.9).
For women, 143 (32.8%) had low SMI, 179 (41.1%) had low physical
performance and 70 (16.1%) had both, meeting criteria for sarcopenia.
The age-specific pattern for the prevalence of sarcopenia in women
differed to that seen in men, whereby the prevalence increased from
9.5% (95% CI 4.2, 17.9) for age 60-64 years to 25.8% (95% CI 17.1,
36.2) for age 75-79 years, followed by a decrease to 15.2% (95% CI 6.3,
28.9) for age 80-84 years and 19.0% (95% CI 10.2, 30.9) for age 85+
years (Figure 1).
The age-standardised prevalence of sarcopenia for women aged 60
years and older was 14.5% (95% CI 10.8, 18.3). Sarcopenia was
associated with lower physical activity scores (age-adjusted mean 9.9
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(8.5-11.5) vs 13.1 (12.4-13.9), p<0.001) and an increased likelihood
falls (age-adjusted OR 1.87 (95% CI 1.11, 3.14), p=0.02). No
interaction terms were identified for models developed for men and
women.
Discussion
Sarcopenia is common among older individuals and data from our
study reports a prevalence ranging of 7.7-13.4% for men and
10.8-18.3% for women aged 60 years and older. These prevalence
figures are within the broad range of estimates reported from other
community-based studies from across the world, which range from
1-29% [9], with higher prevalence estimates reported for clinical
settings and aged-care institutions [9,10].
Sarcopenia
All Yes No
Men n=624 n=81 n=543 P-value
Age (yr) 74.3
(67.4-81.4)
79.0
(73.1-84.0)
73.7
(66.7-80.6)
<0.001
Weight (kg) 81.0 (13.5) 86.8 (12.3) 80.1 (13.4) <0.001
Height (m) 1.72 (0.07) 1.70 (0.06) 1.72 (0.07) 0.01
BMI (kg/m2)a 27.3 (4.0) 29.9 (3.6) 27.0 (4.0) <0.001
Lean mass
(kg)
55.5 (6.8) 53.4 (6.2) 55.9 (6.9) 0.001
SMI (%)b 69.3 (6.8) 61.8 (3.8) 70.5 (6.4) <0.001
TUG (s)c 8.7
(7.6-10.2)
12.0
(10.9-13.7)
8.4 (7.4-9.6) <0.001
Physical
activityd
14.1
(8.3-21.8)
7.8
(3.0-14.7)
15.1
(9.3-22.5)
<0.001
Fallers 203 (32.5%) 30 (37.0%) 173 (31.9%) 0.3
Women n=436 n=70 n=366
Age (yr) 73.6
(66.8-80.0)
77.0
(70.6-80.6)
72.8
(66.3-79.9)
0.006
Weight (kg) 68.2 (13.2) 79.6 (14.2) 66.1 (11.9) <0.001
Height (m) 1.57 (0.06) 1.57 (0.07) 1.72 (0.06) 0.7
BMI (kg/m2)a 27.5 (5.0) 32.1 (4.7) 26.6 (4.6) <0.001
Lean mass
(kg)
37.0 (4.4) 37.6 (5.8) 36.9 (4.1) 0.4
SMI (%)b 55.4 (7.7) 47.5 (3.9) 56.9 (7.3) <0.001
TUG (s)c 12.4
(7.5-18.4)
12.0
(10.6-13.7)
8.8
(7.8-10.5)
<0.001
Physical
activityd
9.5
(8.0-11.6)
8.8
(5.8-14.0)
13.0
(7.9-19.2)
<0.001
Fallers 175 (40.1%) 38 (54.3%) 137 (37.4%) 0.08
aBody Mass Index; bSkeletal Mass index; cTimed Up-and-Go; dQuestionnaire
scores [8]
Table 1: Subject characteristics for all men and women, and according
to sarcopenia status. Data are shown as mean (±SD), median
(interquartile range, IQR) or number (%).
After the age of about 50 years, skeletal muscle mass declines by an
estimated 1-2% per year [11]. Our findings also showed an age-related
decrease in lean tissue mass; however, the negative correlation between
lean tissue mass and age was dissipated when the lean tissue mass was
expressed as the SMI. It seems that for this group of older individuals,
age-related changes in body composition have altered the relative
proportions of fat and lean tissue that contribute to body mass [12,13].
While the reasons for this remain unclear, we might speculate that the
fat-to-lean tissue mass ratio changes as a consequence of hormonal
and lifestyle changes that might include increasingly sedentary
behaviour and poor nutrition during ageing.
As factors that cause losses in skeletal muscle mass and function
might differ [14], it is not perhaps surprising that age-related declines
in muscle strength surpass expectations from corresponding declines
in muscle mass [15]. Some reports highlight the substantial impact that
losses of muscle strength and performance have on functional status,
loss of independence and poor mobility associated with sarcopenia
[11,16]. Ageing skeletal muscle is characterised by changes in
composition and material properties, loss of motor units and
conversion of the fast type II muscle fibres into slow type I fibres,
which reduces muscle power [17]. Further, muscle atrophy that occurs
in the face of obesity in a condition referred to as sarcopenic obesity,
leads to lipid deposits in muscle fibres that reduce muscle strength [18]
and this can occur without a net loss, and indeed sometimes a gain, in
body weight. It is interesting to note that we report greater body weight
and BMI among individuals with sarcopenia and that this difference
persisted after adjusting for age. This finding corroborates other
reports [19,20].
Figure 1: Age-related prevalence of low skeletal mass index (SMI),
low performance and sarcopenia. Data are presented separately for
men and women and error bars represent 95% confidence intervals.
We recognise several strengths and weaknesses in our study. Major
strengths include the random selection of study participants from the
broad population, and the clinical measures of skeletal muscle mass
and function. In contrast to Janssen and colleagues who used estimates
of skeletal muscle mass from bioimpedance analysis measurements to
calculate SMI, we have used DXA measures while retaining the cut-
point of one standard deviation below young adult values to identify
low skeletal muscle mass (values below this cut-point being equivalent
to type 1 sarcopenia) [6]. We cannot exclude the possibility that a
higher TUG threshold might have better identified fallers and/or those
with poorer physical function [21,22]. If alternative thresholds had
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been employed to identify both low skeletal muscle mass from DXA
measures, and low muscle function from TUG performances, or
indeed if other clinical measures had been used to identify low skeletal
muscle mass and function, individuals with and without sarcopenia
might have been segregated differently. However, diverse criteria have
been used extensively in the literature because of the absence of a
widely-accepted operational definition for the condition. We also
acknowledge that we cannot use our study findings to infer causality.
Our cross-sectional analyses suggest that sarcopenia is associated with
low levels of physical activity and high falls risk (at least in women) but
it remains unclear whether or not the association is bi-directional.
Further, it is possible that sarcopenia and the propensity to be
physically inactive and/or a faller might share common risk factors.
In conclusion, we report that the prevalence of sarcopenia is greatest
for women aged 70-79 years and affects one-third of elderly men, aged
85 years and older. Our data suggest that sarcopenia is detected in
approximately 10.6% of men and 14.5% women aged 60 years and
older. Men and women with sarcopenia are habitually less active and,
for women, sarcopenia is associated with increased likelihood of
sustaining a fall. Prospective data are now being sought to identify risk
factors for sarcopenia and its components, low skeletal muscle mass
and function.
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